LNA Santé SA engages in the management and operation of health establishments.
LNA Santé Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€52.00|
|52 Week High||€43.00|
|52 Week Low||€58.80|
|1 Month Change||-5.46%|
|3 Month Change||-0.95%|
|1 Year Change||13.29%|
|3 Year Change||-2.62%|
|5 Year Change||58.06%|
|Change since IPO||394.30%|
Recent News & Updates
|LNA||FR Healthcare||FR Market|
Return vs Industry: LNA exceeded the French Healthcare industry which returned 10.9% over the past year.
Return vs Market: LNA underperformed the French Market which returned 40.1% over the past year.
Stable Share Price: LNA is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: LNA's weekly volatility (2%) has been stable over the past year.
About the Company
LNA Santé SA engages in the management and operation of health establishments. The company operates nursing homes, follow-up care and rehabilitation facilities, home hospitalization structures, health centers, and psychiatric clinics. It serves patients with complex, acute, and chronic pathologies comprising cardiovascular, neurological, and locomotor disorders.
LNA Santé Fundamentals Summary
|LNA fundamental statistics|
Is LNA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LNA income statement (TTM)|
|Cost of Revenue||€425.68m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||1.72|
|Net Profit Margin||2.59%|
How did LNA perform over the long term?See historical performance and comparison
0.4%Current Dividend Yield
Is LNA Santé undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LNA (€52) is trading below our estimate of fair value (€104.64)
Significantly Below Fair Value: LNA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: LNA is good value based on its PE Ratio (30.2x) compared to the French Healthcare industry average (34.4x).
PE vs Market: LNA is poor value based on its PE Ratio (30.2x) compared to the French market (21.1x).
Price to Earnings Growth Ratio
PEG Ratio: LNA is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: LNA is overvalued based on its PB Ratio (2.5x) compared to the FR Healthcare industry average (2.2x).
How is LNA Santé forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LNA's forecast earnings growth (25% per year) is above the savings rate (0.4%).
Earnings vs Market: LNA's earnings (25% per year) are forecast to grow faster than the French market (11.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LNA's revenue (7.7% per year) is forecast to grow faster than the French market (6.3% per year).
High Growth Revenue: LNA's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LNA's Return on Equity is forecast to be low in 3 years time (14%).
How has LNA Santé performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LNA has a large one-off loss of €14.3M impacting its June 30 2021 financial results.
Growing Profit Margin: LNA's current net profit margins (2.6%) are higher than last year (2.3%).
Past Earnings Growth Analysis
Earnings Trend: LNA's earnings have declined by 9.4% per year over the past 5 years.
Accelerating Growth: LNA's earnings growth over the past year (31.2%) exceeds its 5-year average (-9.4% per year).
Earnings vs Industry: LNA earnings growth over the past year (31.2%) underperformed the Healthcare industry 31.2%.
Return on Equity
High ROE: LNA's Return on Equity (8.4%) is considered low.
How is LNA Santé's financial position?
Financial Position Analysis
Short Term Liabilities: LNA's short term assets (€299.3M) do not cover its short term liabilities (€499.0M).
Long Term Liabilities: LNA's short term assets (€299.3M) do not cover its long term liabilities (€777.2M).
Debt to Equity History and Analysis
Debt Level: LNA's debt to equity ratio (222.5%) is considered high.
Reducing Debt: LNA's debt to equity ratio has reduced from 247.5% to 222.5% over the past 5 years.
Debt Coverage: LNA's debt is well covered by operating cash flow (24.1%).
Interest Coverage: LNA's interest payments on its debt are well covered by EBIT (3.2x coverage).
What is LNA Santé current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: LNA's dividend (0.38%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.28%).
High Dividend: LNA's dividend (0.38%) is low compared to the top 25% of dividend payers in the French market (3.93%).
Stability and Growth of Payments
Stable Dividend: LNA is not paying a notable dividend for the French market, therefore no need to check if payments are stable.
Growing Dividend: LNA is not paying a notable dividend for the French market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: LNA is not paying a notable dividend for the French market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LNA's dividend in 3 years as they are not forecast to pay a notable one for the French market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Jean Siret (70 yo)
Mr. Jean paul siret has been the Chairman and Chief Executive Officer of le noble-age., since july 30, 1992. He also serves as Founder of LNA Santé SA. Mr. Siret served as the chief executive officer of sa...
CEO Compensation Analysis
Compensation vs Market: Jean's total compensation ($USD396.96K) is about average for companies of similar size in the French market ($USD501.32K).
Compensation vs Earnings: Jean's compensation has been consistent with company performance over the past year.
Experienced Board: LNA's board of directors are considered experienced (8.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
LNA Santé SA's employee growth, exchange listings and data sources
- Name: LNA Santé SA
- Ticker: LNA
- Exchange: ENXTPA
- Founded: 1990
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €497.366m
- Shares outstanding: 9.56m
- Website: https://www.lna-sante.com
Number of Employees
- LNA Santé SA
- 7 Boulevard Auguste Priou
- PO Box 32336
- Pays de la Loire
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/24 22:58|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.